|
|
Cardiology: Ambulatory Reading List
| You may need to
log in to the Health SmartLibrary before you can
view any of the full-text articles in the following list.
For articles from MD Consult, we can only provide a link to the journal in MD Consult (not directly to the article). Users will need to search for the article within the MD Consult database. Please see relevant articles in the reading lists for further instructions.
Material from UpToDate can only be accessed in NMH, NU Chicago, or NU Evanston buildings. Remote access is not permitted.
|
| Concerning Copyright Restrictions |
The Copyright law of the United States (Title 17, United States
Code) governs the making of photocopies or other reproductions
of copyright material. Under certain conditions specified in the
law, libraries and archives are authorized to furnish a photocopy
or other reproduction, which is not to be "used for any purposes
other than private study, scholarship or research." If a user
makes a request for, or later uses, a photocopy or reproduction
for purposes in excess of "fair use", that user may be
liable for copyright infringement.
- Kitzman DW, Little WC, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288:2144-50.
- Kawaguchi M, Hay I, et al. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction. Circulation 2003; 107:714.
- Bristow M. Antiadrenergic therapy of chronic heart failure. Circulation 2003; 107:1100.
- Arnold JMO, Yusuf S, et al. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation 2003; 107:1284.
- Pitt B, Zannad F, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709-17.
- Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001; 345, 23:1689-97.
- Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function. Epidemilogy, clinical characteristics, and prognosis. J Am Coll Cardiol 2004; 43:317-27.
- Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation 2003; 108:2596-603.
- Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350:1953-9.
- Ridker PM, Rifai N, et al. Measurement of c-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344:1959-65.
- Cleeman JI. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285, 19: 2486-97.
- Ferrier KE, Muhlmann MH, et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002; 39:1020-5.
- Heart Protection Study. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360:7-22.
- Thies F, Garry JMC, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 2003; 361:477-85.
- Kjeldse SE, Dahlof B, et al. Effects of Losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A Losartan Intervention for Endpoint Reduction (LIFE) Substudy. JAMA 2002; 288:1491-8.
- August P. Initial treatment of hypertension. N Engl J Med 2003; 348:610-7.
- ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. JAMA 2002; 288:2981-97.
- Wing LMH, Reid CM, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348:583-92.
- Benetos A, Thomas F, et al. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 2002; 162:577-81.
- Vasan RS, Larson MG, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-7.
- Goldschlager N, Esptein AE, et al. Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med 2003; 163:151-62.
- Eagle KA, Berger PB, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105:1257-67.
- Steinhubl SR, Berger PB, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. JAMA 2002; 288:2411-20.
- Gibbons RJ, Abrams J, et al. ACC/AHA guideline update for the management of patients with chronic stable angina—summary article: a report of the ACC/AHA Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107:149.
- The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825-33.
- Henderson RA, Pocock SJ, et al. Seven-year outcome in the RITA-2 Trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003; 42:1161-70.
- Rihal CS, Raco DL, et al. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina. Circulation 2003; 108:2439-45.
- Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation 2003; 108:2432-8.
- Fox KA. Poole-Wilson P. Clayton TC. Henderson RA. Shaw TR. Wheatley DJ. Knight R. Pocock SJ. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet. 366(9489):914-20, 2005
- Cho L. Bhatt DL. Marso SP. Brennan D. Holmes DR Jr. Califf RM. Topol EJ. An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial. Am J Med. 114(2):106-11, 2003.
- Flaherty JD, Davidson CJ. Diabetes and Coronary Revascularization. JAMA 2005; 293: 1501.
|
